Table 2 Patient characteristics at follow-up depending on the presence of baseline sleep-disordered breathing

BMI, kg/m²

31.5 (17.1; 45.8)

31.6 (17.1; 45.8)

31.2 (25.9; 37.1)

0.91

Number of antihypertensive drugs, n

4 (0; 6)

4 (0; 5)

4 (2; 6)

0.80

Creatinine, mcmol/l

83 (43.4; 139)

83 (43.4; 139.0)

72 (58.0; 99.9)

0.36

Δ Creatinine, mcmol/l

4 (-53; 30)

4 (-34; 22)

2.5 (-53; 30)

0.36

eGFR, ml/min/1.73 m²

79.5 (48; 124)

78 (48; 124)

96 (59.0; 109.0)

0.07

Δ eGFR, ml/min/1.73 m²

-5.98 (-31.2; 38)

-10.5 (-30.2; 36.0)

-0.2 (-22; 38)

0.36

Glucose, mmol/l

5.3 (4.3; 8.8)

5.2 (4.38; 8.80)

5.35 (4.30; 6.07)

0.73

Total cholesterol, mmol/l

4.9 (3.6; 8.3)

5.0 (4.0; 6.6)

4.8 (3.6; 7.1)

0.82

LDL-cholesterol, mmol/l

3.1 (1.5; 4.1)

3.2 (1.5; 4.1)

3.0 (2.4; 4.0)

0.68

Office heart rate, bpm

65 (51; 99)

63 (51; 87)

66 (60; 88)

0.49

Office SBP, mmHg

140 (110; 200)

140 (110; 200)

135 (120; 175)

0.60

Office DBP, mmHg

86 (65; 120)

88 (65; 120)

80 (70; 120)

0.78

Office pulse BP, mmHg

55 (40; 100)

56 (40; 100)

50 (43; 75)

0.60

Mean 24 h SBP, mmHg

138.5 (112; 192)

139 (112; 182)

137 (120; 192)

0.91

Mean 24 h DBP, mmHg

83 (66; 111)

83 (66; 105)

83 (72; 89)

0.69

Mean daytime SBP, mmHg

142 (114; 198)

140 (114; 181)

143 (125; 198)

0.80

Mean daytime DBP, mmHg

87 (69; 115)

87 (69; 107)

85 (75; 106)

0.69

Mean nighttime SBP, mmHg

135 (97; 187)

136 (97; 187)

116 (108; 173)

0.40

Mean nighttime DBP, mmHg

77 (56; 103)

80 (56; 102)

74 (61; 91)

0.59

Non-dipping 24-h SBP profile, n (%)

14 (50%)

12 (75%)

2 (17%)

χ² = 6.86, p = 0.009

Daytime BP load, %

67 (5.5; 100)

58 (5.5; 100)

69 (21; 100)

0.79

Nighttime BP load, %

94 (0; 100)

94 (0; 100)

74 (24; 100)

0.64

ESS, score

6.5 (2.0; 14.0)

6.5 (2.0; 8.0)

5.0 (3.0; 14.0)

0.73